Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine

BACKGROUND: Migraine is a painful neurological disorder that affects over 10% of the general population. Frovatriptan and rizatriptan are antimigraine agents belonging to the triptan class. Although previous studies have independently compared the efficacy of these agents, contemporaneous data exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Savi, Lidia, Mogavero, Selene, Egan, Colin Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112748/
https://www.ncbi.nlm.nih.gov/pubmed/25092964
http://dx.doi.org/10.2147/DDDT.S61295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112748/
https://www.ncbi.nlm.nih.gov/pubmed/25092964
http://dx.doi.org/10.2147/DDDT.S61295

Ejemplares similares